Wholesale gardening tools too late
2019年10月29日India loses one child every eight minutes to pneumococcal disease. Pneumococcus resides in the nose and throat passages of a large proportion of healthy children. This was in the mid-1990s, and pneumococcus was a familiar harbinger of death in very young children. The act of immunising them with this vaccine virtually wipes out the strains of pneumococcus in the vaccine from the nose and throat of children who are vaccinated. His mother could not believe how quickly things deteriorated. Overall this vaccine has been shown to prevent the death and suffering of numerous cases of pneumococcal disease.As the vaccine becomes an integral part of the national immunisation programme over the next few years, far fewer precious lives will be lost unnecessarily.Dr Anita Shet is a pediatrician and public health infectious disease specialist, and serves as an Associate Scientist for the International Vaccine Access Centre at Johns Hopkins University. More than one-fifth of the deaths globally due to pneumococcus occurs in India.The pneumococcal vaccine launch slated to take place at Mandi, Himachal Pradesh, on Saturday, May 13, this year is a laudable milestone for India and the world. As doctors working in a district hospital in southern India, etched behind our hopeful façade, was frustration at the lack of effective tools that could prevent this devastating illness.Dr Mathuram Santosham is a pediatrician and a public health expert, who serves as Senior Advisor for IVAC at the Johns Hopkins University, where he is also a Professor of International Health and Pediatrics.Today, as pediatricians and public health specialists, we are grateful for and encouraged by the tools we now have to prevent pneumonia, including new vaccines. "His fever just began yesterday", she wept, "will he live now?"Our medical team was in rapid response mode. By starting in the highest burden areas in India, the government is taking a wise and brave decision. Fortunately, in our toolkit today, we have a safe and effective vaccine against pneumococcus called pneumococcal conjugate vaccine (PCV). Yet, much work remains. Pneumococcal vaccines have been given to millions of children around the world and have been shown to be safe. In India, one child dies from a pneumococcus-related illness every eight minutes. This makes treatment even more complicated and expensive
.Children under five years of age are most vulnerable to disease caused by pneumococcus. Some strains of pneumococcus, of which there are more than 90, are resistant to commonly used antibiotics. The strategy of vaccinating the youngest individuals has an added bonus — it also provides protection to the rest of the population, through a phenomenon termed "herd protection". Among children who survive meningitis, more than a quarter suffer from serious neurological consequences such as deafness, paralysis and mental deficiency.It was a momentous occasion when the first PCV was licensed in the United States for use in infants and young children in 2000. How can we accept this?Antibiotics are excellent tools to treat illnesses caused by pneumococcus. Pneumococcus is a bacterium that can cause diseases such as pneumonia and meningitis. Countries that have introduced the vaccine have seen substantial reductions in hospitalisation rates for pneumonia in children within a few years of introducing the vaccine. Unfortunately, they are often administered https://www.hwugu.com/ too late. Today, India is taking initial steps to bring this vaccine to every child. These conditions are responsible for untold suffering and economic hardships in many thousands of families.Little Raju was rushed in by his anxious parents into the emergency room; the 10-month-old infant was struggling to breathe and turning blue despite his high fever.Pneumococcus is a leading cause of vaccine-preventable illness and death among children less than five years of age in India and the world.Some have asked, "How well does this vaccine work?" The vaccine India will introduce provides protection against more than two-thirds of all the strains that cause serious disease in children both here and in other similar countries.
Clinical trials from around the world have shown that children who receive PCV are about 80 per cent protected from getting a serious pneumococcal infection caused by a strain present in the vaccine. Most of these strains have been captured into the pneumococcal vaccine.. While more than 90 different strains of pneumococcus can cause repeated illnesses, only a handful cause most of the severe disease. This reduces disease transmission and indirectly helps prevent individuals who are too young or too old to be immunised from being getting sick from pneumococcal disease. We applaud the decision of the Government of India to introduce this lifesaving vaccine that will save children’s lives, reduce suffering, and see healthier children go on to become productive adults. Oxygen and antibiotics were in place to treat his severe pneumonia, but without a ventilator or breathing machine, that was rare in a small hospital like ours, his chance of survival was tenuous.India will stand firmly with the global community and more than 130 countries who have already introduced PCV in their health programmes, including our neighbours Pakistan, Afghanistan, Nepal, and Bangladesh. However, these bacteria also affect other age groups, particularly older children and elderly individuals above 65 years of age. It is important that the hardest-to-reach children have easy access to this vaccine.India’s vote is certainly a win for children like Raju and for the country. Today, there is a vaccine to help reduce the far-reaching effects of this deadly disease.
.Children under five years of age are most vulnerable to disease caused by pneumococcus. Some strains of pneumococcus, of which there are more than 90, are resistant to commonly used antibiotics. The strategy of vaccinating the youngest individuals has an added bonus — it also provides protection to the rest of the population, through a phenomenon termed "herd protection". Among children who survive meningitis, more than a quarter suffer from serious neurological consequences such as deafness, paralysis and mental deficiency.It was a momentous occasion when the first PCV was licensed in the United States for use in infants and young children in 2000. How can we accept this?Antibiotics are excellent tools to treat illnesses caused by pneumococcus. Pneumococcus is a bacterium that can cause diseases such as pneumonia and meningitis. Countries that have introduced the vaccine have seen substantial reductions in hospitalisation rates for pneumonia in children within a few years of introducing the vaccine. Unfortunately, they are often administered https://www.hwugu.com/ too late. Today, India is taking initial steps to bring this vaccine to every child. These conditions are responsible for untold suffering and economic hardships in many thousands of families.Little Raju was rushed in by his anxious parents into the emergency room; the 10-month-old infant was struggling to breathe and turning blue despite his high fever.Pneumococcus is a leading cause of vaccine-preventable illness and death among children less than five years of age in India and the world.Some have asked, "How well does this vaccine work?" The vaccine India will introduce provides protection against more than two-thirds of all the strains that cause serious disease in children both here and in other similar countries.
Clinical trials from around the world have shown that children who receive PCV are about 80 per cent protected from getting a serious pneumococcal infection caused by a strain present in the vaccine. Most of these strains have been captured into the pneumococcal vaccine.. While more than 90 different strains of pneumococcus can cause repeated illnesses, only a handful cause most of the severe disease. This reduces disease transmission and indirectly helps prevent individuals who are too young or too old to be immunised from being getting sick from pneumococcal disease. We applaud the decision of the Government of India to introduce this lifesaving vaccine that will save children’s lives, reduce suffering, and see healthier children go on to become productive adults. Oxygen and antibiotics were in place to treat his severe pneumonia, but without a ventilator or breathing machine, that was rare in a small hospital like ours, his chance of survival was tenuous.India will stand firmly with the global community and more than 130 countries who have already introduced PCV in their health programmes, including our neighbours Pakistan, Afghanistan, Nepal, and Bangladesh. However, these bacteria also affect other age groups, particularly older children and elderly individuals above 65 years of age. It is important that the hardest-to-reach children have easy access to this vaccine.India’s vote is certainly a win for children like Raju and for the country. Today, there is a vaccine to help reduce the far-reaching effects of this deadly disease.
コメント